This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.
Audiences:
Health Professionals
Focus Area:
TB
Subjects:
Diagnosis
Treatment Guidelines Materials
Diagnosis- Screening
Publication Date:
2010
Format:
Guideline
Last Updated Date:
Publication ID:
33606